PT76459B - Process for preparing substituted 3,4-diamino-1,2,process for the preparation of 3,4-diamino-1,2,5-tiadiazoles substituted with anti-histaminic activi5-thiadiazoles having histamine h2-receptor antagoty nist activity - Google Patents

Process for preparing substituted 3,4-diamino-1,2,process for the preparation of 3,4-diamino-1,2,5-tiadiazoles substituted with anti-histaminic activi5-thiadiazoles having histamine h2-receptor antagoty nist activity

Info

Publication number
PT76459B
PT76459B PT76459A PT7645983A PT76459B PT 76459 B PT76459 B PT 76459B PT 76459 A PT76459 A PT 76459A PT 7645983 A PT7645983 A PT 7645983A PT 76459 B PT76459 B PT 76459B
Authority
PT
Portugal
Prior art keywords
diamino
substituted
tiadiazoles
antagoty
activi5
Prior art date
Application number
PT76459A
Other languages
Portuguese (pt)
Other versions
PT76459A (en
Inventor
Ronnie Ray Crenshaw
Aldo Antonio Algieri
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of PT76459A publication Critical patent/PT76459A/en
Publication of PT76459B publication Critical patent/PT76459B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/06—1,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PT76459A 1982-03-29 1983-03-28 Process for preparing substituted 3,4-diamino-1,2,process for the preparation of 3,4-diamino-1,2,5-tiadiazoles substituted with anti-histaminic activi5-thiadiazoles having histamine h2-receptor antagoty nist activity PT76459B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36320782A 1982-03-29 1982-03-29

Publications (2)

Publication Number Publication Date
PT76459A PT76459A (en) 1983-04-01
PT76459B true PT76459B (en) 1986-03-11

Family

ID=23429274

Family Applications (1)

Application Number Title Priority Date Filing Date
PT76459A PT76459B (en) 1982-03-29 1983-03-28 Process for preparing substituted 3,4-diamino-1,2,process for the preparation of 3,4-diamino-1,2,5-tiadiazoles substituted with anti-histaminic activi5-thiadiazoles having histamine h2-receptor antagoty nist activity

Country Status (30)

Country Link
JP (2) JPS58180477A (en)
KR (1) KR880002209B1 (en)
AT (1) AT386599B (en)
AU (2) AU557577B2 (en)
BE (1) BE896291A (en)
CH (2) CH660880A5 (en)
CS (2) CS250240B2 (en)
DD (2) DD219768A5 (en)
DE (1) DE3311281A1 (en)
DK (2) DK166677B1 (en)
ES (3) ES520982A0 (en)
FR (2) FR2542741B1 (en)
GB (2) GB2117769B (en)
GR (1) GR78524B (en)
HU (2) HU196386B (en)
IE (1) IE55596B1 (en)
IL (1) IL68259A0 (en)
IT (1) IT1164633B (en)
LU (1) LU84716A1 (en)
MY (1) MY8700942A (en)
NL (1) NL8301063A (en)
NO (1) NO163055C (en)
NZ (1) NZ203726A (en)
OA (1) OA07356A (en)
PT (1) PT76459B (en)
SE (2) SE461040B (en)
SU (2) SU1419518A3 (en)
YU (1) YU44849B (en)
ZA (1) ZA832154B (en)
ZW (1) ZW7683A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives
US4593039A (en) * 1984-04-02 1986-06-03 Merck & Co., Inc. 1-aryloxy-3-(substituted aminoalkylamino)-2-propanols
US4644006A (en) * 1984-06-22 1987-02-17 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
JPH0622828B2 (en) * 1986-06-30 1994-03-30 フアナツク株式会社 Direct pressure type mold clamping mechanism
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3018289A (en) * 1960-02-10 1962-01-23 Wyandotte Chemicals Corp Process for preparing oxamidines
GB1595291A (en) * 1976-09-21 1981-08-12 Smith Kline French Lab Pyrimidone and thiopyrimidone derivatives
NL189197C (en) * 1979-09-04 1993-02-01 Bristol Myers Squibb Co 3,4-SUBSTITUTED-1,2,5-THIADIAZOLO-1-OXIDES AND 1,1-DIOXIDES, PREPARATION THEREOF, AND PHARMACEUTICAL PREPARATIONS.
DE3175201D1 (en) * 1980-04-30 1986-10-02 Merck & Co Inc Aminothiadiazoles as gastric secretion inhibitors
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives

Also Published As

Publication number Publication date
GB2117769A (en) 1983-10-19
OA07356A (en) 1984-08-31
ES8404683A1 (en) 1984-05-16
MY8700942A (en) 1987-12-31
ES8505978A1 (en) 1985-06-16
FR2597867A1 (en) 1987-10-30
NO163055B (en) 1989-12-18
SE8704689L (en) 1987-11-25
DE3311281A1 (en) 1983-11-24
NL8301063A (en) 1983-10-17
FR2597867B1 (en) 1989-12-08
FR2542741A1 (en) 1984-09-21
DD219768A5 (en) 1985-03-13
IE830686L (en) 1983-09-29
GR78524B (en) 1984-09-27
NZ203726A (en) 1986-05-09
ZA832154B (en) 1983-12-28
ES8505977A1 (en) 1985-06-16
SU1355123A3 (en) 1987-11-23
DD210909A5 (en) 1984-06-27
DK141383D0 (en) 1983-03-28
ATA111083A (en) 1988-02-15
DK81192D0 (en) 1992-06-18
AU6327286A (en) 1987-01-08
SU1419518A3 (en) 1988-08-23
AU586037B2 (en) 1989-06-29
GB2149406B (en) 1986-01-02
AU1290783A (en) 1983-10-06
DK81192A (en) 1992-06-18
SE8301725D0 (en) 1983-03-28
JPS58180477A (en) 1983-10-21
IE55596B1 (en) 1990-11-21
IT8348005A0 (en) 1983-03-28
GB2149406A (en) 1985-06-12
HU196386B (en) 1988-11-28
YU74483A (en) 1986-02-28
YU44849B (en) 1991-04-30
DK166677B1 (en) 1993-06-28
AT386599B (en) 1988-09-12
CS250229B2 (en) 1987-04-16
IL68259A0 (en) 1983-06-15
GB8308518D0 (en) 1983-05-05
KR880002209B1 (en) 1988-10-18
AU557577B2 (en) 1986-12-24
JPH0568472B2 (en) 1993-09-29
SE461040B (en) 1989-12-18
HU188742B (en) 1986-05-28
CH655111A5 (en) 1986-03-27
GB2117769B (en) 1985-08-29
SE464302B (en) 1991-04-08
PT76459A (en) 1983-04-01
JPH06135925A (en) 1994-05-17
ES527685A0 (en) 1985-06-16
FR2542741B1 (en) 1989-12-08
IT1164633B (en) 1987-04-15
DK141383A (en) 1983-09-30
LU84716A1 (en) 1983-12-05
ES520982A0 (en) 1984-05-16
KR840004095A (en) 1984-10-06
CS250240B2 (en) 1987-04-16
ES527686A0 (en) 1985-06-16
NO163055C (en) 1990-03-28
NO831100L (en) 1983-09-30
ZW7683A1 (en) 1984-01-04
BE896291A (en) 1983-09-28
GB8432809D0 (en) 1985-02-06
SE8704689D0 (en) 1987-11-25
CH660880A5 (en) 1987-05-29
SE8301725L (en) 1983-11-25

Similar Documents

Publication Publication Date Title
PT81733A (en) Process for the preparation of 2-(2'-nitrobenzoyl)-1,3-cyclohexadionas
PT81731A (en) Process for the preparation of 2-(2'-alkylbenzoyl)-1,3-ciclohexadions
EP0133913A3 (en) Process for the preparation of 3,3-dichloro-2-methyl propene
ZA807871B (en) 2-chloro -4,6-diamino -s-triazines as algicides
IE791406L (en) Process for preparing h2-receptor antagonist, cimetidine
DE2961327D1 (en) Process for the preparation of 1,4-diazabicyclo-(2,2,2) octane
PT76459B (en) Process for preparing substituted 3,4-diamino-1,2,process for the preparation of 3,4-diamino-1,2,5-tiadiazoles substituted with anti-histaminic activi5-thiadiazoles having histamine h2-receptor antagoty nist activity
IL70470A (en) Intermediate for the preparation of ceftazidime,its preparation and process for preparing ceftazidime
ZA813284B (en) Novel substituted pyrazinyl-1,2,4-oxadiazoles and process for preparing the same
DE3065368D1 (en) Process for preparing n,n'-(1,2-ethylene)-bis-tetrabromophthalimide
IL62842A0 (en) Process for the preparation of n-di-n-propyl-2,6-dinitro-4-trifluoro-methylaniline
DE3563351D1 (en) Process for the preparation of tetrachloro-benzo-1,4-dioxenes
DE3360040D1 (en) Process for the preparation of 2,3-dichlorobutadiene-1,3
DE3371509D1 (en) Clavulone derivatives, process for preparing the same, and use of said compounds
DE2860107D1 (en) Process for the preparation of 4,6-dihalogeno-1,3,5-triazines
PT75481A (en) Process for preparing 3'-substituted-5'-(2-amino-4-pyridil)-1',2',4',-triazoles
DE3369121D1 (en) Process for the preparation of disulphides
PT76687B (en) Process for preparing quinazoline cardiac stimulants
DE3361226D1 (en) Process for the preparation of 1-azolyl-3,3-dimethyl-1-phenoxy-butan-2-oles
PT80684A (en) Process for preparing substituted 3,4-diamino-1,2,5-thiadiazoles having histamine h2-receptor antagonist activity and of pharmaceutical compositions containing the same
EP0095569A3 (en) Process for the preparation of phenylpyridazine compounds
DE3377217D1 (en) Process for the preparation of monobenzoylated 1,4-diaminoanthraquinones
DE3361627D1 (en) Process for the preparation of 5-aryloxy-1-chloro-3,3-dimethyl-pentan-2-ones
DE2965015D1 (en) Process for the preparation of 1,3,4-thiadiazoles
DE3462690D1 (en) Method for the preparation of 4-amino-3-ethylthio-6-tert.-butyl-1,2,4-triazine-5-one virtually free of isomers

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19950930